Investment
Features
FeesSafety
Academy
More
Pluang+

Metaplex launches Vantage, a new Solana asset-trading platform for research, tracking, and trading.

Protocol Fundamentals
23 Sep 2026
Tokenpost
View Source
Bullish
Metaplex launches Vantage, a new Solana asset-trading platform for research, tracking, and trading.

Metaplex has introduced Vantage, a trading platform designed to expand its Solana ecosystem beyond token creation and launches. Vantage focuses on researching, tracking, and trading Solana-based assets, enhancing Metaplex's tools for navigating on-chain markets. This move builds on Metaplex's existing offerings, including the Metaplex App and Genesis framework, supporting over $14 billion in trading volume and more than 1 billion digital assets created. Vantage aims to serve users actively engaged in Solana-based markets, broadening Metaplex's role in the blockchain space.

Metaplex's launch of Vantage as a Solana asset trading platform is the story's focus, offered here with Pluang's market snapshot as of Sep 23, 2026 22:05 WIB: Among 50 major cryptocurrencies tradable on Pluang, 14 rose and 35 fell today. Notable movers include COTI with a 7.62% increase and 78% buy order activity, BCH up 7.00% but with 63% sell orders, and XNO down 7.81% with 58% buy orders. This breadth data reflects diverse market activity across the crypto sector on Pluang.

More News

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

Jefferies analysts set a new price target of $435 for General Electric Aerospace, implying a 35% upside from its current price of around $321. GE Aerospace's strong position is supported by a $170 billion commercial services backlog and 80,000 aircra...

Analyst Insights
Bullish
2 hours ago
BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas lowered its price target for PepsiCo from $183 to $161 on September 23, 2026, due to ongoing demand challenges in North America. Despite the cut, the firm maintained an Outperform rating, indicating confidence in the stock's potential. Th...

Analyst Insights
Bearish
3 hours ago
Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex Therapeutics saw its price target raised from $70 to $88 by Leerink Partners following successful Phase III trial results for its drug barzolvolimab treating chronic spontaneous urticaria (CSU). The trials met all primary endpoints, showing l...

Analyst Insights
Bullish
3 hours ago
Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper, a major copper producer, shows stock volatility between $16.88 and $40.83 over the past year. Analyst firm CIBC maintained a "Neutral" rating but increased the price target to C$56.00, reflecting optimism about the company's long-term gro...

Analyst Insights
Bullish
3 hours ago
Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas Corporation posted robust first-quarter results, surpassing analyst expectations with earnings per share of $1.39 and revenue of $3.01 billion, a 10.9% increase year-over-year. The company's organic revenue growth was 8.9%, reflecting solid bu...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App